{"id":1135,"date":"2022-04-25T11:46:45","date_gmt":"2022-04-25T11:46:45","guid":{"rendered":"http:\/\/cordonsdevie.org\/?page_id=1135"},"modified":"2025-05-08T11:28:28","modified_gmt":"2025-05-08T11:28:28","slug":"draft","status":"publish","type":"page","link":"https:\/\/cordonsdevie.org\/?page_id=1135&lang=fr","title":{"rendered":"Projets de recherche scientifique"},"content":{"rendered":"<p>[vc_row unlock_row=&#8221;&#8221; row_height_percent=&#8221;0&#8243; back_color=&#8221;color-xsdn&#8221; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; css=&#8221;.vc_custom_1654177569924{margin-top: 30px !important;}&#8221;][vc_column width=&#8221;1\/1&#8243;][vc_button button_color=&#8221;color-126273&#8243; size=&#8221;btn-xl&#8221; wide=&#8221;yes&#8221; outline=&#8221;yes&#8221; border_width=&#8221;0&#8243; icon_position=&#8221;right&#8221; link=&#8221;url:http%3A%2F%2Fcordonsdevie.org%2F%3Fpage_id%3D181%26lang%3Dfr|||&#8221; icon=&#8221;fa fa-heart&#8221;]FAITES UN DON[\/vc_button][vc_tabs][vc_tab gutter_size=&#8221;2&#8243; column_padding=&#8221;2&#8243; title=&#8221;2024&#8243; tab_id=&#8221;1733133321497-9-8&#8243;][vc_row_inner row_inner_height_percent=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; css=&#8221;.vc_custom_1651239577016{margin-bottom: 50px !important;}&#8221; limit_content=&#8221;&#8221;][vc_column_inner column_width_percent=&#8221;100&#8243; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/3&#8243; css=&#8221;.vc_custom_1746448368154{padding-top: 30px !important;}&#8221;][vc_single_image media=&#8221;1679&#8243; media_width_percent=&#8221;100&#8243;][\/vc_column_inner][vc_column_inner column_width_percent=&#8221;100&#8243; position_horizontal=&#8221;left&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;2\/3&#8243;][vc_column_text]<\/p>\n<h4 style=\"color: #d2214a; text-align: left;\">AN\u00c9MIE DE FANCONI<\/h4>\n<p>[\/vc_column_text][vc_column_text]Le projet a pour objectif de mod\u00e9liser le ph\u00e9notype att\u00e9nu\u00e9 dans l\u2019an\u00e9mie de Fanconi, en \u00e9tudiant le g\u00e9nome et la dynamique des cellules att\u00e9nu\u00e9es. A plus long terme, ce ph\u00e9notype pourrait \u00eatre reproduit dans un but th\u00e9rapeutique afin de compenser l\u2019insuffisance m\u00e9dullaires et de pr\u00e9venir les leuc\u00e9mies.[\/vc_column_text][vc_column_text]<strong><em>Pr Jean SOULIER<\/em><\/strong> \u2013 INSERM U944 \u2013 H\u00f4pital Saint Louis Paris[\/vc_column_text][vc_message message_color=&#8221;accent&#8221;]Financement de Cordons de vie sur 2 ans : 10.000 euros par an. D\u00e9marrage en 2024[\/vc_message][\/vc_column_inner][\/vc_row_inner][vc_row_inner row_inner_height_percent=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; css=&#8221;.vc_custom_1651239577016{margin-bottom: 50px !important;}&#8221; limit_content=&#8221;&#8221;][vc_column_inner column_width_percent=&#8221;100&#8243; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/3&#8243; css=&#8221;.vc_custom_1746448368154{padding-top: 30px !important;}&#8221;][vc_single_image media=&#8221;1706&#8243; media_width_percent=&#8221;100&#8243;][\/vc_column_inner][vc_column_inner column_width_percent=&#8221;100&#8243; position_horizontal=&#8221;left&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;2\/3&#8243;][vc_column_text]<\/p>\n<h4 style=\"color: #d2214a; text-align: left;\">CR\u00c9ATION D\u2019UN SYST\u00c8ME INFORMATIQUE DE RECUEIL DES DONN\u00c9ES DE PATIENTS DR\u00c9PANOCYTAIRES AU S\u00c9N\u00c9GAL.<\/h4>\n<p>[\/vc_column_text][vc_column_text]L\u2019\u00e9tude pr\u00e9voit la cr\u00e9ation et la validation d\u2019un questionnaire pour collecter les donn\u00e9es sur support papier et informatique (e-CRF) afin de permettre de faire l\u2019\u00e9tude des corr\u00e9lations entre les complications de la dr\u00e9panocytose et son profil immunog\u00e9n\u00e9tiqu.[\/vc_column_text][vc_column_text]<strong><em>Dr Barbara CAPELLI<\/em><\/strong><em> \u2013 <\/em>Eurocord Paris \u2013 CSM Monaco[\/vc_column_text][vc_message message_color=&#8221;accent&#8221;]Financement de Cordons de vie sur 2 ans : 10.000 euros par an. D\u00e9marrage en 2024[\/vc_message][\/vc_column_inner][\/vc_row_inner][\/vc_tab][vc_tab title=&#8221;2021&#8243; tab_id=&#8221;1650886886167-8-6&#8243;][vc_row_inner row_inner_height_percent=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; css=&#8221;.vc_custom_1651239577016{margin-bottom: 50px !important;}&#8221; limit_content=&#8221;&#8221;][vc_column_inner column_width_percent=&#8221;100&#8243; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/3&#8243; css=&#8221;.vc_custom_1746448326187{padding-top: 30px !important;}&#8221;][vc_single_image media=&#8221;1689&#8243; media_width_percent=&#8221;100&#8243;][\/vc_column_inner][vc_column_inner column_width_percent=&#8221;100&#8243; position_horizontal=&#8221;left&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;2\/3&#8243;][vc_column_text]<\/p>\n<h4 style=\"color: #d2214a; text-align: left;\">INFLUENCE DES POLYMORPHISMES NUCL\u00c9OTIDIQUES (SNPS) DU G\u00c8NE HLA-DRB1 SUR LES R\u00c9SULTATS DES GREFFES DE CELLULES SOUCHES DANS LA DR\u00c9PANOCYTOSE.<\/h4>\n<p>[\/vc_column_text][vc_column_text]C\u2019est un projet de recherche pure qui \u00e9tudie les polymorphismes g\u00e9n\u00e9tiques des syst\u00e8mes de compatibilit\u00e9 tissulaire dans les populations dr\u00e9panocytaires.\u00a0 Cette \u00e9tude permet d\u2019\u00e9tudier la fonction et non le g\u00e8ne lui-m\u00eame. Elle porte sur une fonction pr\u00e9cise du g\u00e8ne FEY en position 26-28-30 pour HLA DRB1. Le but est de mieux pr\u00e9venir les complications d\u2019une greffe et de choisir les donneurs. C\u2019est une nouvelle approche en amont de la transplantation qui est dans l\u2019objet de l\u2019association.[\/vc_column_text][vc_column_text]<em><strong>Docteur Graziana Maria SCIGLIUOLO VUOLO<\/strong><\/em> \u2013 Centre Scientifique de Monaco \u2013 Equipe du Professeur Gluckman.[\/vc_column_text][vc_message message_color=&#8221;accent&#8221;]Poursuite du projet initi\u00e9 en 2020, budget allou\u00e9 sur 2 ans: \u00a010.000 euros[\/vc_message][\/vc_column_inner][\/vc_row_inner][vc_row_inner row_inner_height_percent=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; css=&#8221;.vc_custom_1651239577016{margin-bottom: 50px !important;}&#8221; limit_content=&#8221;&#8221;][vc_column_inner column_width_percent=&#8221;100&#8243; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/3&#8243; css=&#8221;.vc_custom_1746448338875{padding-top: 30px !important;}&#8221;][vc_single_image media=&#8221;1690&#8243; media_width_percent=&#8221;100&#8243;][\/vc_column_inner][vc_column_inner column_width_percent=&#8221;100&#8243; position_horizontal=&#8221;left&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;2\/3&#8243;][vc_column_text]<\/p>\n<h4 style=\"color: #d2214a; text-align: left;\">OPTIMAL ALLOGENEIC MESENCHYMAL STROMAL CELLS (MSC) FOR TREATING SCLERODERMA: BONE MARROW- OR UMBILICAL CORD- DERIVED MSC.<\/h4>\n<p>[\/vc_column_text][vc_column_text]Ce projet a pour objet de comparer des cellules souches m\u00e9senchymateuses de la moelle ou du cordon ombilical pour voir celles qui pourraient \u00eatre le plus efficaces dans le traitement de la scl\u00e9rodermie. Recherche de haut niveau parfaitement dans l\u2019objet de l\u2019association.[\/vc_column_text][vc_column_text]<em><strong>Professeur Dominique FARGE<\/strong><\/em> &#8211; H\u00f4pital Saint Louis Paris[\/vc_column_text][vc_message message_color=&#8221;accent&#8221;]Poursuite du projet initi\u00e9 en 2020, budget allou\u00e9 sur 2 ans: \u00a07.500 euros[\/vc_message][\/vc_column_inner][\/vc_row_inner][vc_row_inner row_inner_height_percent=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; css=&#8221;.vc_custom_1651239577016{margin-bottom: 50px !important;}&#8221; limit_content=&#8221;&#8221;][vc_column_inner column_width_percent=&#8221;100&#8243; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/3&#8243; css=&#8221;.vc_custom_1746448350827{padding-top: 30px !important;}&#8221;][vc_single_image media=&#8221;1691&#8243; media_width_percent=&#8221;100&#8243;][\/vc_column_inner][vc_column_inner column_width_percent=&#8221;100&#8243; position_horizontal=&#8221;left&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;2\/3&#8243;][vc_column_text]<\/p>\n<h4 style=\"color: #d2214a; text-align: left;\">LES CYTOKINES ELR+CXCL DANS LES CANCERS DU REIN M\u00c9TASTATIQUES ET LES M\u00c9DULLOBLASTOMES : DE NOUVELLES CIBLES TH\u00c9RAPEUTIQUES PERTINENTES CHEZ LES PATIENTS EN RECHUTE.<\/h4>\n<p>[\/vc_column_text][vc_column_text]Il s\u2019agit d\u2019une \u00e9tude de th\u00e9rapie cibl\u00e9e pour traiter le cancer du rein et les m\u00e9dulloblastomes de l\u2019enfant. Certaines tumeurs d\u00e9veloppent en surface des substances qui emp\u00eachent les lymphocytes d\u2019attaquer la tumeur. Le principe est de neutraliser ces inhibiteurs pour que la fonction immunologique des lymphocytes fonctionne. Ce projet a \u00e9t\u00e9 soumis par le Centre Scientifique de Monaco et rentre dans l\u2019extension des statuts.[\/vc_column_text][vc_column_text]<em><strong>Docteur Gilles PAGES<\/strong><\/em> \u2013 Centre Scientifique de Monaco.[\/vc_column_text][vc_message message_color=&#8221;accent&#8221;]Poursuite du projet initi\u00e9 en 2020, budget allou\u00e9 sur 2 ans: \u00a05.000 euros[\/vc_message][\/vc_column_inner][\/vc_row_inner][\/vc_tab][vc_tab title=&#8221;2020&#8243; tab_id=&#8221;1650886877038-7-2&#8243;][vc_row_inner row_inner_height_percent=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; css=&#8221;.vc_custom_1651239577016{margin-bottom: 50px !important;}&#8221; limit_content=&#8221;&#8221;][vc_column_inner column_width_percent=&#8221;100&#8243; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/3&#8243; css=&#8221;.vc_custom_1746448389634{padding-top: 30px !important;}&#8221;][vc_single_image media=&#8221;1689&#8243; media_width_percent=&#8221;100&#8243;][\/vc_column_inner][vc_column_inner column_width_percent=&#8221;100&#8243; position_horizontal=&#8221;left&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;2\/3&#8243;][vc_column_text]<\/p>\n<h4 style=\"color: #d2214a; text-align: left;\">INFLUENCE DES POLYMORPHISMES NUCL\u00c9OTIDIQUES (SNPS) DU G\u00c8NE HLA-DRB1 SUR LES R\u00c9SULTATS DES GREFFES DE CELLULES SOUCHES DANS LA DR\u00c9PANOCYTOSE.<\/h4>\n<p>[\/vc_column_text][vc_column_text]C\u2019est un projet de recherche pure qui \u00e9tudie les polymorphismes g\u00e9n\u00e9tiques des syst\u00e8mes de compatibilit\u00e9 tissulaire dans les populations dr\u00e9panocytaires.\u00a0 Cette \u00e9tude permet d\u2019\u00e9tudier la fonction et non le g\u00e8ne lui-m\u00eame. Elle porte sur une fonction pr\u00e9cise du g\u00e8ne FEY en position 26-28-30 pour HLA DRB1. Le but est de mieux pr\u00e9venir les complications d\u2019une greffe et de choisir les donneurs. C\u2019est une nouvelle approche en amont de la transplantation qui est dans l\u2019objet de l\u2019association.[\/vc_column_text][vc_column_text]<em><strong>Docteur Graziana Maria SCIGLIUOLO VUOLO<\/strong><\/em> \u2013 Centre Scientifique de Monaco \u2013 Equipe du Professeur Gluckman.[\/vc_column_text][vc_message message_color=&#8221;accent&#8221;]Budget allou\u00e9 sur 2 ans: 10.000 euros[\/vc_message][\/vc_column_inner][\/vc_row_inner][vc_row_inner row_inner_height_percent=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; css=&#8221;.vc_custom_1651239577016{margin-bottom: 50px !important;}&#8221; limit_content=&#8221;&#8221;][vc_column_inner column_width_percent=&#8221;100&#8243; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/3&#8243; css=&#8221;.vc_custom_1746448418139{padding-top: 30px !important;}&#8221;][vc_single_image media=&#8221;1690&#8243; media_width_percent=&#8221;100&#8243;][\/vc_column_inner][vc_column_inner column_width_percent=&#8221;100&#8243; position_horizontal=&#8221;left&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;2\/3&#8243;][vc_column_text]<\/p>\n<h4 style=\"color: #d2214a; text-align: left;\">OPTIMAL ALLOGENEIC MESENCHYMAL STROMAL CELLS (MSC) FOR TREATING SCLERODERMA: BONE MARROW- OR UMBILICAL CORD- DERIVED MSC.<\/h4>\n<p>[\/vc_column_text][vc_column_text]Ce projet a pour objet de comparer des cellules souches m\u00e9senchymateuses de la moelle ou du cordon ombilical pour voir celles qui pourraient \u00eatre le plus efficaces dans le traitement de la scl\u00e9rodermie. Recherche de haut niveau parfaitement dans l\u2019objet de l\u2019association.[\/vc_column_text][vc_column_text]<em><strong>Professeur Dominique FARGE<\/strong><\/em> &#8211; H\u00f4pital Saint Louis Paris[\/vc_column_text][vc_message message_color=&#8221;accent&#8221;]Budget allou\u00e9 sur deux ans: 7.500 euros[\/vc_message][\/vc_column_inner][\/vc_row_inner][vc_row_inner row_inner_height_percent=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; css=&#8221;.vc_custom_1651239577016{margin-bottom: 50px !important;}&#8221; limit_content=&#8221;&#8221;][vc_column_inner column_width_percent=&#8221;100&#8243; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/3&#8243; css=&#8221;.vc_custom_1746448454395{padding-top: 30px !important;}&#8221;][vc_single_image media=&#8221;1691&#8243; media_width_percent=&#8221;100&#8243;][\/vc_column_inner][vc_column_inner column_width_percent=&#8221;100&#8243; position_horizontal=&#8221;left&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;2\/3&#8243;][vc_column_text]<\/p>\n<h4 style=\"color: #d2214a; text-align: left;\">LES CYTOKINES ELR+CXCL DANS LES CANCERS DU REIN M\u00c9TASTATIQUES ET LES M\u00c9DULLOBLASTOMES : DE NOUVELLES CIBLES TH\u00c9RAPEUTIQUES PERTINENTES CHEZ LES PATIENTS EN RECHUTE.<\/h4>\n<p>[\/vc_column_text][vc_column_text]Il s\u2019agit d\u2019une \u00e9tude de th\u00e9rapie cibl\u00e9e pour traiter le cancer du rein et les m\u00e9dulloblastomes de l\u2019enfant. Certaines tumeurs d\u00e9veloppent en surface des substances qui emp\u00eachent les lymphocytes d\u2019attaquer la tumeur. Le principe est de neutraliser ces inhibiteurs pour que la fonction immunologique des lymphocytes fonctionne. Ce projet a \u00e9t\u00e9 soumis par le Centre Scientifique de Monaco et rentre dans l\u2019extension des statuts.[\/vc_column_text][vc_column_text]<em><strong>Docteur Gilles PAGES<\/strong><\/em> \u2013 Centre Scientifique de Monaco.[\/vc_column_text][vc_message message_color=&#8221;accent&#8221;]Budget allou\u00e9 sur 2 ans: 5.000euros[\/vc_message][\/vc_column_inner][\/vc_row_inner][\/vc_tab][vc_tab title=&#8221;2019&#8243; tab_id=&#8221;1650886869553-6-4&#8243;][vc_row_inner row_inner_height_percent=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; css=&#8221;.vc_custom_1651239577016{margin-bottom: 50px !important;}&#8221; limit_content=&#8221;&#8221;][vc_column_inner column_width_percent=&#8221;100&#8243; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/3&#8243; css=&#8221;.vc_custom_1746448486792{padding-top: 30px !important;}&#8221;][vc_single_image media=&#8221;1694&#8243; media_width_percent=&#8221;100&#8243;][\/vc_column_inner][vc_column_inner column_width_percent=&#8221;100&#8243; position_horizontal=&#8221;left&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;2\/3&#8243;][vc_column_text]<\/p>\n<h4 style=\"color: #d2214a; text-align: left;\">ETUDE COMPARATIVE DES GREFFES DE CELLULES SOUCHES DU CORDON OMBILICAL ET LA GREFFE HAPLO IDENTIQUE POUR LES ENFANTS ATTEINTS DE LEUC\u00c9MIES AIGUES<\/h4>\n<p>[\/vc_column_text][vc_column_text]Le projet va permettre de comparer 2 m\u00e9thodes de greffes. L\u2019une utilise des cellules adultes dont les cellules lymphocytaires sont \u00e9limin\u00e9es par des anticorps monoclonaux, l\u2019autre utilise des cellules du sang de cordon ombilical fournies par les banques et non manipul\u00e9es. Les r\u00e9sultats vont \u00eatre compar\u00e9s sur le long terme notamment en ce qui concerne la reconstitution immunitaire et le risque de rechute leuc\u00e9mique.[\/vc_column_text][vc_column_text]<em><strong>Pr Franco LOCATELLI<\/strong>\u00a0et\u00a0<strong>Analisa RUGGIERI<\/strong><\/em>\u00a0Ospedale Pediatrico Bambino Gesu \u2013 ROME \u2013 Italie[\/vc_column_text][vc_message message_color=&#8221;accent&#8221;]Poursuite du projet initi\u00e9 en 2018, budget allou\u00e9 sur 2 ans: 20.000 euros[\/vc_message][\/vc_column_inner][\/vc_row_inner][vc_row_inner row_inner_height_percent=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; css=&#8221;.vc_custom_1651239577016{margin-bottom: 50px !important;}&#8221; limit_content=&#8221;&#8221;][vc_column_inner column_width_percent=&#8221;100&#8243; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/3&#8243; css=&#8221;.vc_custom_1746448496572{padding-top: 30px !important;}&#8221;][vc_single_image media=&#8221;1695&#8243; media_width_percent=&#8221;100&#8243;][\/vc_column_inner][vc_column_inner column_width_percent=&#8221;100&#8243; position_horizontal=&#8221;left&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;2\/3&#8243;][vc_column_text]<\/p>\n<h4 style=\"color: #d2214a; text-align: left;\">ETUDE DE LA TOL\u00c9RANCE ET DE L\u2019EFFICACIT\u00c9 DE L\u2019INJECTION DE CELLULES SOUCHES M\u00c9SENCHYMATEUSES CHEZ LES ADULTES ATTEINTS D\u2019AUTISME DE HAUT NIVEAU<\/h4>\n<p>[\/vc_column_text][vc_column_text]Il s\u2019agit d\u2019une \u00e9tude de phase I-II qui va \u00e9tudier l\u2019injection de cellules m\u00e9senchymateuses chez des patients autistes adultes. Seule la toxicit\u00e9 sera mesur\u00e9e accessoirement l\u2019am\u00e9lioration de l\u2019\u00e9tat du patient. Les injections sont faites en ambulatoire, le patient \u00e9tant accompagn\u00e9. La chercheuse est une jeune Japonaise en th\u00e8se de doctorat en science.[\/vc_column_text][vc_column_text]<em><strong>Dr Marion LEBOYER \/ Hiromi HAYASHI<\/strong><\/em>\u00a0\u2013 Universit\u00e9 Paris XIII \u2013 Eurocord \u2013 H\u00f4pital Saint Louis France.[\/vc_column_text][vc_message message_color=&#8221;accent&#8221;]Poursuite du projet initi\u00e9 en 2018, budget allou\u00e9 sur 2 ans: 12.500 euros[\/vc_message][\/vc_column_inner][\/vc_row_inner][vc_row_inner row_inner_height_percent=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; css=&#8221;.vc_custom_1651239577016{margin-bottom: 50px !important;}&#8221; limit_content=&#8221;&#8221;][vc_column_inner column_width_percent=&#8221;100&#8243; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/3&#8243; css=&#8221;.vc_custom_1746448514850{padding-top: 30px !important;}&#8221;][vc_single_image media=&#8221;1433&#8243; media_width_percent=&#8221;100&#8243;][\/vc_column_inner][vc_column_inner column_width_percent=&#8221;100&#8243; position_horizontal=&#8221;left&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;2\/3&#8243;][vc_column_text]<\/p>\n<h4 style=\"color: #d2214a; text-align: left;\">OPTIMISATION DES PROTOCOLES DE TRANSPLANTATION DE CELLULES SOUCHES H\u00c9MATOPO\u00cf\u00c9TIQUES<\/h4>\n<p>[\/vc_column_text][vc_column_text]Le projet a pour objet de travailler sur l\u2019optimisation de la culture des cellules souches en utilisant des agents anti oxydants pour am\u00e9liorer le rendement et l\u2019efficacit\u00e9 des cellules souches du sang de cordon ombilical. Ces \u00e9tudes sont un pr\u00e9alable important pour optimiser les techniques de th\u00e9rapie g\u00e9nique.[\/vc_column_text][vc_column_text]<em><strong>Dr Marie Laure ARCANGELI<\/strong><\/em>\u00a0\u2013 INSERM \u2013 France[\/vc_column_text][vc_message message_color=&#8221;accent&#8221;]Poursuite du projet initi\u00e9 en 2018, budget allou\u00e9 sur 2 ans: 12.500 euros[\/vc_message][\/vc_column_inner][\/vc_row_inner][vc_row_inner row_inner_height_percent=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; css=&#8221;.vc_custom_1651239577016{margin-bottom: 50px !important;}&#8221; limit_content=&#8221;&#8221;][vc_column_inner column_width_percent=&#8221;100&#8243; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/3&#8243; css=&#8221;.vc_custom_1746448523018{padding-top: 30px !important;}&#8221;][vc_single_image media=&#8221;1428&#8243; media_width_percent=&#8221;100&#8243;][\/vc_column_inner][vc_column_inner column_width_percent=&#8221;100&#8243; position_horizontal=&#8221;left&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;2\/3&#8243;][vc_column_text]<\/p>\n<h4 style=\"color: #d2214a; text-align: left;\">MESURER LE R\u00d4LE D\u2019UN NOUVEAU TRAITEMENT POUR L\u2019AUTISME.<\/h4>\n<p>[\/vc_column_text][vc_column_text]Le chercheur Ryad TAMOUZA- INSERM H\u00f4pital Henri Mondor, de Paris \u00e9tudie ici l\u2019immunoth\u00e9rapie dans le cas de l\u2019autisme en mettant en place un protocole de mesure de l\u2019impact. Cette \u00e9quipe de recherche est appuy\u00e9e par l\u2019Association Cordons de Vie depuis de nombreuses ann\u00e9es, raison pour laquelle il a \u00e9t\u00e9 d\u00e9cid\u00e9 de poursuivre cet appui.[\/vc_column_text][vc_column_text]<strong><em>Docteur\u00a0Ryad TAMOUZA<\/em> &#8211; <\/strong>INSERN H\u00f4pital Henry Mondor[\/vc_column_text][vc_message message_color=&#8221;accent&#8221;]Budget allou\u00e9 : 5\u00a0000 euros[\/vc_message][\/vc_column_inner][\/vc_row_inner][\/vc_tab][vc_tab title=&#8221;2018&#8243; tab_id=&#8221;1650886861597-5-1&#8243;][vc_row_inner row_inner_height_percent=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; css=&#8221;.vc_custom_1651239577016{margin-bottom: 50px !important;}&#8221; limit_content=&#8221;&#8221;][vc_column_inner column_width_percent=&#8221;100&#8243; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/3&#8243; css=&#8221;.vc_custom_1746448675361{padding-top: 30px !important;}&#8221;][vc_single_image media=&#8221;1695&#8243; media_width_percent=&#8221;100&#8243;][\/vc_column_inner][vc_column_inner column_width_percent=&#8221;100&#8243; position_horizontal=&#8221;left&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;2\/3&#8243;][vc_column_text]<\/p>\n<h4 style=\"color: #d2214a; text-align: left;\">DEVENIR DES TROUBLES AUTISTIQUES APR\u00c8S GREFFE DE CELLULES SOUCHES H\u00c9MATOPO\u00cf\u00c9TIQUES POUR UNE H\u00c9MOPATHIE<\/h4>\n<p>[\/vc_column_text][vc_column_text]\u00c9tude collaborative : Eurocord et Unit\u00e9 de Psychiatrique Translationelle.[\/vc_column_text][vc_column_text]Des \u00e9tudes r\u00e9centes laissent supposer que les patients atteints de troubles du spectre autistique trait\u00e9s par greffe de cellules souches pour une autre pathologie, pourraient voir un impact positif sur les signes de l\u2019autisme. Projet novateur, ouvrant des pistes de recherches extr\u00eamement int\u00e9ressantes.[\/vc_column_text][vc_column_text]<strong><em>Marion LEBOYER<\/em> \u2013<\/strong>\u00a0PARIS EUROCORD.[\/vc_column_text][vc_message message_color=&#8221;accent&#8221;]Poursuite du projet initi\u00e9 en 2017, budget allou\u00e9 sur 2 ans: 20.000 euros[\/vc_message][\/vc_column_inner][\/vc_row_inner][vc_row_inner row_inner_height_percent=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; css=&#8221;.vc_custom_1651239577016{margin-bottom: 50px !important;}&#8221; limit_content=&#8221;&#8221;][vc_column_inner column_width_percent=&#8221;100&#8243; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/3&#8243; css=&#8221;.vc_custom_1746448686026{padding-top: 30px !important;}&#8221;][vc_single_image media=&#8221;1689&#8243; media_width_percent=&#8221;100&#8243;][\/vc_column_inner][vc_column_inner column_width_percent=&#8221;100&#8243; position_horizontal=&#8221;left&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;2\/3&#8243;][vc_column_text]<\/p>\n<h4 style=\"color: #d2214a; text-align: left;\">ETUDE DU R\u00d4LE DU POLYMORPHISME G\u00c9N\u00c9TIQUE SUR L\u2019\u00c9VOLUTION CLINIQUE DE LA DR\u00c9PANOCYTOSE.<\/h4>\n<p>[\/vc_column_text][vc_column_text]Cette \u00e9tude va permettre de calculer la probabilit\u00e9 de trouver un donneur compatible, mais \u00e9galement de d\u00e9terminer les patients pour lesquels les greffes seraient les plus indiqu\u00e9es. Cette \u00e9tude s\u2019appuiera sur les donn\u00e9es de l\u2019h\u00f4pital Tenon, sur l\u2019Universit\u00e9 de Sao Paulo au Br\u00e9sil, et sur le centre de r\u00e9f\u00e9rence de la dr\u00e9panocytose de Saint Louis au S\u00e9n\u00e9gal.[\/vc_column_text][vc_column_text]<strong><em>Annalisa RUGGIERI<\/em> \u2013<\/strong>\u00a0Paris EUROCORD.[\/vc_column_text][vc_message message_color=&#8221;accent&#8221;]Poursuite du projet initi\u00e9 en 2017, budget allou\u00e9 sur 2 ans: 20.000 euros[\/vc_message][\/vc_column_inner][\/vc_row_inner][vc_row_inner row_inner_height_percent=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; css=&#8221;.vc_custom_1651239577016{margin-bottom: 50px !important;}&#8221; limit_content=&#8221;&#8221;][vc_column_inner column_width_percent=&#8221;100&#8243; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/3&#8243; css=&#8221;.vc_custom_1746448699248{padding-top: 30px !important;}&#8221;][vc_single_image media=&#8221;1697&#8243; media_width_percent=&#8221;100&#8243;][\/vc_column_inner][vc_column_inner column_width_percent=&#8221;100&#8243; position_horizontal=&#8221;left&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;2\/3&#8243;][vc_column_text]<\/p>\n<h4 style=\"color: #d2214a; text-align: left;\">ETUDE COMPARATIVE DES GREFFES DE CELLULES SOUCHES DU CORDON OMBILICAL ET LA GREFFE HAPLO IDENTIQUE POUR LES ENFANTS ATTEINTS DE LEUC\u00c9MIES AIGUES<\/h4>\n<p>[\/vc_column_text][vc_column_text]Le projet va permettre de comparer 2 m\u00e9thodes de greffes. L\u2019une utilise des cellules adultes dont les cellules lymphocytaires sont \u00e9limin\u00e9es par des anticorps monoclonaux, l\u2019autre utilise des cellules du sang de cordon ombilical fournies par les banques et non manipul\u00e9es. Les r\u00e9sultats vont \u00eatre compar\u00e9s sur le long terme notamment en ce qui concerne la reconstitution immunitaire et le risque de rechute leuc\u00e9mique.[\/vc_column_text][vc_column_text]<em><strong>Pr Franco LOCATELLI<\/strong>\u00a0et\u00a0<strong>Analisa RUGGIERI<\/strong><\/em>\u00a0Ospedale Pediatrico Bambino Gesu \u2013 ROME \u2013 Italie[\/vc_column_text][vc_message message_color=&#8221;accent&#8221;]Budget allou\u00e9 sur 2 ans : 20.000 euros[\/vc_message][\/vc_column_inner][\/vc_row_inner][vc_row_inner row_inner_height_percent=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; css=&#8221;.vc_custom_1651239577016{margin-bottom: 50px !important;}&#8221; limit_content=&#8221;&#8221;][vc_column_inner column_width_percent=&#8221;100&#8243; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/3&#8243; css=&#8221;.vc_custom_1746448718737{padding-top: 30px !important;}&#8221;][vc_single_image media=&#8221;1695&#8243; media_width_percent=&#8221;100&#8243;][\/vc_column_inner][vc_column_inner column_width_percent=&#8221;100&#8243; position_horizontal=&#8221;left&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;2\/3&#8243;][vc_column_text]<\/p>\n<h4 style=\"color: #d2214a; text-align: left;\">ETUDE DE LA TOL\u00c9RANCE ET DE L\u2019EFFICACIT\u00c9 DE L\u2019INJECTION DE CELLULES SOUCHES M\u00c9SENCHYMATEUSES CHEZ LES ADULTES ATTEINTS D\u2019AUTISME DE HAUT NIVEAU<\/h4>\n<p>[\/vc_column_text][vc_column_text]Il s\u2019agit d\u2019une \u00e9tude de phase I-II qui va \u00e9tudier\u00a0 l\u2019injection de cellules m\u00e9senchymateuses chez des patients autistes adultes. Seule la toxicit\u00e9 sera mesur\u00e9e accessoirement l\u2019am\u00e9lioration de l\u2019\u00e9tat du patient. Les injections sont faites en ambulatoire, le patient \u00e9tant accompagn\u00e9. La chercheuse est une jeune Japonaise en th\u00e8se de doctorat en science.[\/vc_column_text][vc_column_text]<em><strong>Dr Marion LEBOYER \/ Hiromi HAYASHI<\/strong><\/em>\u00a0\u2013 Universit\u00e9 Paris XIII \u2013 Eurocord \u2013 H\u00f4pital Saint Louis France.[\/vc_column_text][vc_message message_color=&#8221;accent&#8221;]Budget allou\u00e9 sur 2 ans : 12.500 euros[\/vc_message][\/vc_column_inner][\/vc_row_inner][vc_row_inner row_inner_height_percent=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; css=&#8221;.vc_custom_1651239577016{margin-bottom: 50px !important;}&#8221; limit_content=&#8221;&#8221;][vc_column_inner column_width_percent=&#8221;100&#8243; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/3&#8243; css=&#8221;.vc_custom_1746448731130{padding-top: 30px !important;}&#8221;][vc_single_image media=&#8221;1433&#8243; media_width_percent=&#8221;100&#8243;][\/vc_column_inner][vc_column_inner column_width_percent=&#8221;100&#8243; position_horizontal=&#8221;left&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;2\/3&#8243;][vc_column_text]<\/p>\n<h4 style=\"color: #d2214a; text-align: left;\">OPTIMISATION DES PROTOCOLES DE TRANSPLANTATION DE CELLULES SOUCHES H\u00c9MATOPO\u00cf\u00c9TIQUES<\/h4>\n<p>[\/vc_column_text][vc_column_text]Le projet a pour objet de travailler sur l\u2019optimisation de la culture des cellules souches en utilisant des agents anti oxydants pour am\u00e9liorer le rendement et l\u2019efficacit\u00e9 des cellules souches du sang de cordon ombilical. Ces \u00e9tudes sont un pr\u00e9alable important pour optimiser les techniques de th\u00e9rapie g\u00e9nique.[\/vc_column_text][vc_column_text]<em><strong>Dr Marie Laure ARCANGELI<\/strong><\/em>\u00a0\u2013 INSERM \u2013 France[\/vc_column_text][vc_message message_color=&#8221;accent&#8221;]Budget allou\u00e9 sur 2 ans : 12.500 euros[\/vc_message][\/vc_column_inner][\/vc_row_inner][vc_row_inner row_inner_height_percent=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; css=&#8221;.vc_custom_1651239577016{margin-bottom: 50px !important;}&#8221; limit_content=&#8221;&#8221;][vc_column_inner column_width_percent=&#8221;100&#8243; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/3&#8243; css=&#8221;.vc_custom_1746448742072{padding-top: 30px !important;}&#8221;][vc_single_image media=&#8221;1694&#8243; media_width_percent=&#8221;100&#8243;][\/vc_column_inner][vc_column_inner column_width_percent=&#8221;100&#8243; position_horizontal=&#8221;left&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;2\/3&#8243;][vc_column_text]<\/p>\n<h4 style=\"color: #d2214a; text-align: left;\">GWAS STUDY IN ACUTE MYELOID LEUKEMIA<\/h4>\n<p>[\/vc_column_text][vc_column_text]Le projet concerne l\u2019\u00e9tude d\u00e9taill\u00e9e de 1.300 cas de leuc\u00e9mies par un bio statisticien. La question est de savoir si certains d\u00e9terminants g\u00e9n\u00e9tiques pr\u00e9disposent \u00e0 la leuc\u00e9mie myeloblastique et si les patients atteints vont r\u00e9pondre au traitement. Ce projet s\u2019appuie sur les nouvelles m\u00e9thodes d\u2019\u00e9tudes statistiques d\u2019analyse de marqueurs mol\u00e9culaires.[\/vc_column_text][vc_column_text]<em><strong>Docteur Thomas CLUZEAU <\/strong><\/em>&#8211; CHU NICE Archet 1 \u2013 INSERM &#8211; France[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_tab][vc_tab title=&#8221;2017&#8243; tab_id=&#8221;1650886854060-4-9&#8243;][vc_row_inner row_inner_height_percent=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; css=&#8221;.vc_custom_1651239577016{margin-bottom: 50px !important;}&#8221; limit_content=&#8221;&#8221;][vc_column_inner column_width_percent=&#8221;100&#8243; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/3&#8243; css=&#8221;.vc_custom_1746448857750{padding-top: 30px !important;}&#8221;][vc_single_image media=&#8221;1697&#8243; media_width_percent=&#8221;100&#8243;][\/vc_column_inner][vc_column_inner column_width_percent=&#8221;100&#8243; position_horizontal=&#8221;left&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;2\/3&#8243;][vc_column_text]<\/p>\n<h4 style=\"color: #d2214a; text-align: left;\">COMPARAISON DES CAPACIT\u00c9S DES CELLULES SOUCHES DE SANG DE CORDONS ET DES CELLULES SOUCHES DE MOELLE OSSEUSE.<\/h4>\n<p>[\/vc_column_text][vc_column_text]<strong><em>Professeur Timoty DEVOS<\/em>\u00a0\u2013<\/strong>\u00a0H\u00f4pital de Leuven Belgique[\/vc_column_text][vc_message message_color=&#8221;accent&#8221;]Poursuite du projet initi\u00e9 en 2015, budget allou\u00e9 sur 2 ans: 15.000 euros[\/vc_message][\/vc_column_inner][\/vc_row_inner][vc_row_inner row_inner_height_percent=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; css=&#8221;.vc_custom_1651239577016{margin-bottom: 50px !important;}&#8221; limit_content=&#8221;&#8221;][vc_column_inner column_width_percent=&#8221;100&#8243; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/3&#8243; css=&#8221;.vc_custom_1746448868254{padding-top: 30px !important;}&#8221;][vc_single_image media=&#8221;1430&#8243; media_width_percent=&#8221;100&#8243;][\/vc_column_inner][vc_column_inner column_width_percent=&#8221;100&#8243; position_horizontal=&#8221;left&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;2\/3&#8243;][vc_column_text]<\/p>\n<h4 style=\"color: #d2214a; text-align: left;\">DEVENIR DES TROUBLES AUTISTIQUES APR\u00c8S GREFFE DE CELLULES SOUCHES H\u00c9MATOPO\u00cf\u00c9TIQUES POUR UNE H\u00c9MOPATHIE<\/h4>\n<p>[\/vc_column_text][vc_column_text]\u00c9tude collaborative : Eurocord et Unit\u00e9 de Psychiatrique Translationelle.[\/vc_column_text][vc_column_text]Des \u00e9tudes r\u00e9centes laissent supposer que les patients atteints de troubles du spectre autistique trait\u00e9s par greffe de cellules souches pour une autre pathologie, pourraient voir un impact positif sur les signes de l\u2019autisme. Projet novateur, ouvrant des pistes de recherches extr\u00eamement int\u00e9ressantes.[\/vc_column_text][vc_column_text]<strong><em>Marion LEBOYER<\/em> \u2013<\/strong>\u00a0PARIS EUROCORD.[\/vc_column_text][vc_message message_color=&#8221;accent&#8221;]Budget allou\u00e9 sur 2 ans : 20.000 euros[\/vc_message][\/vc_column_inner][\/vc_row_inner][vc_row_inner row_inner_height_percent=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; css=&#8221;.vc_custom_1651239577016{margin-bottom: 50px !important;}&#8221; limit_content=&#8221;&#8221;][vc_column_inner column_width_percent=&#8221;100&#8243; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/3&#8243; css=&#8221;.vc_custom_1746448880711{padding-top: 30px !important;}&#8221;][vc_single_image media=&#8221;1694&#8243; media_width_percent=&#8221;100&#8243;][\/vc_column_inner][vc_column_inner column_width_percent=&#8221;100&#8243; position_horizontal=&#8221;left&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;2\/3&#8243;][vc_column_text]<\/p>\n<h4 style=\"color: #d2214a; text-align: left;\">ETUDE DU R\u00d4LE DU POLYMORPHISME G\u00c9N\u00c9TIQUE SUR L\u2019\u00c9VOLUTION CLINIQUE DE LA DR\u00c9PANOCYTOSE.<\/h4>\n<p>[\/vc_column_text][vc_column_text]Cette \u00e9tude va permettre de calculer la probabilit\u00e9 de trouver un donneur compatible, mais \u00e9galement de d\u00e9terminer les patients pour lesquels les greffes seraient les plus indiqu\u00e9es. Cette \u00e9tude s\u2019appuiera sur les donn\u00e9es de l\u2019h\u00f4pital Tenon, sur l\u2019Universit\u00e9 de Sao Paulo au Br\u00e9sil, et sur le centre de r\u00e9f\u00e9rence de la dr\u00e9panocytose de Saint Louis au S\u00e9n\u00e9gal.[\/vc_column_text][vc_column_text]<strong><em>Annalisa RUGGIERI<\/em> \u2013<\/strong>\u00a0Paris EUROCORD.[\/vc_column_text][vc_message message_color=&#8221;accent&#8221;]Budget allou\u00e9 sur 2 ans : 15.000 euros[\/vc_message][\/vc_column_inner][\/vc_row_inner][vc_row_inner row_inner_height_percent=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; css=&#8221;.vc_custom_1651239577016{margin-bottom: 50px !important;}&#8221; limit_content=&#8221;&#8221;][vc_column_inner column_width_percent=&#8221;100&#8243; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/3&#8243; css=&#8221;.vc_custom_1746448894542{padding-top: 30px !important;}&#8221;][vc_single_image media=&#8221;1689&#8243; media_width_percent=&#8221;100&#8243;][\/vc_column_inner][vc_column_inner column_width_percent=&#8221;100&#8243; position_horizontal=&#8221;left&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;2\/3&#8243;][vc_column_text]<\/p>\n<h4 style=\"color: #d2214a; text-align: left;\">IMPACT DE LA DR\u00c9PANOCYTOSE SUR LES FONCTIONS DU PLACENTA HUMAIN.<\/h4>\n<p>[\/vc_column_text][vc_column_text]Le projet vise \u00e9galement \u00e0 \u00e9valuer l\u2019impact de la dr\u00e9panocytose sur l\u2019\u00e9volution de la grossesse. Le projet est assez original et porte sur l\u2019\u00e9tude de 15 cas et sur des complications extr\u00eamement graves de la grossesse. Cette l\u2019\u00e9tude permettra de confirmer un point de vue d\u00e9j\u00e0 connu. Le projet avait \u00e9t\u00e9 transmis \u00e0 CDV en mai 2016, mais mis en stand by en attendant le Comit\u00e9 Scientifique suivant. Le projet a \u00e9t\u00e9 amend\u00e9 et resoumis.[\/vc_column_text][vc_column_text]<strong><em>Anne Ga\u00ebl CORDIER<\/em> \u2013 <\/strong>H\u00f4pital B\u00e9cl\u00e8re, Clamart[\/vc_column_text][vc_message message_color=&#8221;accent&#8221;]Budget allou\u00e9 en 2017 : 10.000 euros[\/vc_message][\/vc_column_inner][\/vc_row_inner][\/vc_tab][vc_tab title=&#8221;2016&#8243; tab_id=&#8221;1650886842791-3-1&#8243;][vc_row_inner row_inner_height_percent=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; css=&#8221;.vc_custom_1651239577016{margin-bottom: 50px !important;}&#8221; limit_content=&#8221;&#8221;][vc_column_inner column_width_percent=&#8221;100&#8243; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/3&#8243; css=&#8221;.vc_custom_1746448987441{padding-top: 30px !important;}&#8221;][vc_single_image media=&#8221;1694&#8243; media_width_percent=&#8221;100&#8243;][\/vc_column_inner][vc_column_inner column_width_percent=&#8221;100&#8243; position_horizontal=&#8221;left&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;2\/3&#8243;][vc_column_text]<\/p>\n<h4 style=\"color: #d2214a; text-align: left;\">CONTR\u00d4LE DES INFECTIONS VIRALES POST GREFFE<\/h4>\n<p>[\/vc_column_text][vc_column_text]Cette \u00e9tude vise \u00e0 contr\u00f4ler les infections virales, li\u00e9es \u00e0 la cin\u00e9tique de reconstitution des cellules \u00ab\u00a0NK\u00a0\u00bb post greffe. Une meilleure compr\u00e9hension de ces m\u00e9canismes permettra de mieux prendre en charge les infections.[\/vc_column_text][vc_column_text]<strong><em>Professeur Franco LOCATELLI<\/em> \u2013\u00a0<\/strong>Ospedale Pediatrico Bamino Gesu Rome[\/vc_column_text][vc_message message_color=&#8221;accent&#8221;]Poursuite du projet initi\u00e9 en 2015, budget allou\u00e9 sur 2 ans: 15.000 euros[\/vc_message][\/vc_column_inner][\/vc_row_inner][vc_row_inner row_inner_height_percent=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; css=&#8221;.vc_custom_1651239577016{margin-bottom: 50px !important;}&#8221; limit_content=&#8221;&#8221;][vc_column_inner column_width_percent=&#8221;100&#8243; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/3&#8243; css=&#8221;.vc_custom_1746449008870{padding-top: 30px !important;}&#8221;][vc_single_image media=&#8221;1689&#8243; media_width_percent=&#8221;100&#8243;][\/vc_column_inner][vc_column_inner column_width_percent=&#8221;100&#8243; position_horizontal=&#8221;left&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;2\/3&#8243;][vc_column_text]<\/p>\n<h4 style=\"color: #d2214a; text-align: left;\">ANALYSE DES GREFFES DE CELLULES SOUCHES DANS LA LUTTE CONTRE LA DR\u00c9PANOCYTOSE.<\/h4>\n<p>[\/vc_column_text][vc_column_text]Cette analyse va permettre d\u2019\u00e9valuer l\u2019efficacit\u00e9 de ce type de greffe dans le traitement de la dr\u00e9panocytose.[\/vc_column_text][vc_column_text]<strong><em>Docteur Maria CAVAZZANNA<\/em> \u2013\u00a0<\/strong>Institut Imagine \u2013 H\u00f4pital Necker Paris[\/vc_column_text][vc_message message_color=&#8221;accent&#8221;]Poursuite du projet initi\u00e9 en 2015, budget allou\u00e9 sur 2 ans: 15.000 euros[\/vc_message][\/vc_column_inner][\/vc_row_inner][vc_row_inner row_inner_height_percent=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; css=&#8221;.vc_custom_1651239577016{margin-bottom: 50px !important;}&#8221; limit_content=&#8221;&#8221;][vc_column_inner column_width_percent=&#8221;100&#8243; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/3&#8243; css=&#8221;.vc_custom_1746449023094{padding-top: 30px !important;}&#8221;][vc_single_image media=&#8221;1699&#8243; media_width_percent=&#8221;100&#8243;][\/vc_column_inner][vc_column_inner column_width_percent=&#8221;100&#8243; position_horizontal=&#8221;left&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;2\/3&#8243;][vc_column_text]<\/p>\n<h4 style=\"color: #d2214a; text-align: left;\">ETUDE SUR LES INDICATIONS DE LA GREFFE DE CELLULES SOUCHES H\u00c9MATOPO\u00cf\u00c9TIQUES CHEZ LES PATIENTS DR\u00c9PANOCYTAIRES.<\/h4>\n<p>[\/vc_column_text][vc_column_text]<strong><em>Professeur Eliane GLUCKMAN<\/em> \u2013<\/strong>\u00a0Saint Louis \u2013 Paris[\/vc_column_text][vc_message message_color=&#8221;accent&#8221;]Budget allou\u00e9 sur 2 ans : 20.000 euros[\/vc_message][\/vc_column_inner][\/vc_row_inner][vc_row_inner row_inner_height_percent=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; css=&#8221;.vc_custom_1651239577016{margin-bottom: 50px !important;}&#8221; limit_content=&#8221;&#8221;][vc_column_inner column_width_percent=&#8221;100&#8243; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/3&#8243; css=&#8221;.vc_custom_1746449034293{padding-top: 30px !important;}&#8221;][vc_single_image media=&#8221;1689&#8243; media_width_percent=&#8221;100&#8243;][\/vc_column_inner][vc_column_inner column_width_percent=&#8221;100&#8243; position_horizontal=&#8221;left&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;2\/3&#8243;][vc_column_text]<\/p>\n<h4 style=\"color: #d2214a; text-align: left;\">ETUDE SUR LES GREFFES CHEZ LES DR\u00c9PANOCYTAIRES \u00c0 3 ANS<\/h4>\n<p>[\/vc_column_text][vc_column_text]Cette \u00e9tude va permettre d\u2019avoir des donn\u00e9es sur une p\u00e9riode plus longue \u2013 3 ans \u2013 pour pouvoir conclure\u00a0et r\u00e9pondre \u00e0 la question : \u00a0la greffe est elle une vraie solution pour les dr\u00e9panocytaire ?[\/vc_column_text][vc_column_text]<em><strong>Docteur Fran\u00e7oise BERNAUDIN<\/strong><\/em>\u00a0<strong>\u2013\u00a0<\/strong>Centre de R\u00e9f\u00e9rence de la Dr\u00e9panocytose du CHIC (Centre hospitalier Intercommunal de Cr\u00e9teil)[\/vc_column_text][vc_message message_color=&#8221;accent&#8221;]Budget allou\u00e9 sur 2 an : 20.000 euros[\/vc_message][\/vc_column_inner][\/vc_row_inner][vc_row_inner row_inner_height_percent=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; css=&#8221;.vc_custom_1651239577016{margin-bottom: 50px !important;}&#8221; limit_content=&#8221;&#8221;][vc_column_inner column_width_percent=&#8221;100&#8243; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/3&#8243; css=&#8221;.vc_custom_1746449045007{padding-top: 30px !important;}&#8221;][vc_single_image media=&#8221;1435&#8243; media_width_percent=&#8221;100&#8243;][\/vc_column_inner][vc_column_inner column_width_percent=&#8221;100&#8243; position_horizontal=&#8221;left&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;2\/3&#8243;][vc_column_text]<\/p>\n<h4 style=\"color: #d2214a; text-align: left;\">LA MISE AU POINT D\u2019UN COLLYRE ISSU DU S\u00c9RUM DU SANG DE CORDON<\/h4>\n<p>[\/vc_column_text][vc_column_text]L\u2019objectif de l\u2019\u00e9tude est de produire de fa\u00e7on standardis\u00e9e un collyre \u00e0 partir\u00a0du s\u00e9rum du sang de cordon ombilical et contenant des facteurs tissulaires r\u00e9g\u00e9n\u00e9ratifs pour lutter contre la\u00a0s\u00e9cheresse\u00a0oculaire.[\/vc_column_text][vc_column_text]<em><strong>Docteur Paolo REBULLA<\/strong><\/em>\u00a0<strong>\u2013\u00a0<\/strong>Centro Trasfusionale e Milano Cord Bloond Bank &#8211; Italie[\/vc_column_text][vc_message message_color=&#8221;accent&#8221;]Budget allou\u00e9 : 10.000 euros[\/vc_message][\/vc_column_inner][\/vc_row_inner][\/vc_tab][vc_tab title=&#8221;2015&#8243; tab_id=&#8221;1650886774700-2-2&#8243;][vc_row_inner row_inner_height_percent=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; css=&#8221;.vc_custom_1651239577016{margin-bottom: 50px !important;}&#8221; limit_content=&#8221;&#8221;][vc_column_inner column_width_percent=&#8221;100&#8243; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/3&#8243; css=&#8221;.vc_custom_1746449292319{padding-top: 30px !important;}&#8221;][vc_single_image media=&#8221;1694&#8243; media_width_percent=&#8221;100&#8243;][\/vc_column_inner][vc_column_inner column_width_percent=&#8221;100&#8243; position_horizontal=&#8221;left&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;2\/3&#8243;][vc_column_text]<\/p>\n<h4 style=\"color: #d2214a; text-align: left;\">CONTR\u00d4LE DES INFECTIONS VIRALES POST GREFFE<\/h4>\n<p>[\/vc_column_text][vc_column_text]Cette \u00e9tude vise \u00e0 contr\u00f4ler les infections virales, li\u00e9es \u00e0 la cin\u00e9tique de reconstitution des cellules \u00ab\u00a0NK\u00a0\u00bb post greffe. Une meilleure compr\u00e9hension de ces m\u00e9canismes permettra de mieux prendre en charge les infections.[\/vc_column_text][vc_column_text]<strong><em>Professeur Franco LOCATELLI <\/em><\/strong><em>&#8211;<\/em>\u00a0Hopital Bambin Jesus Rome Italie[\/vc_column_text][vc_message message_color=&#8221;accent&#8221;]Budget allou\u00e9 sur 2 ans: 15.000 euros[\/vc_message][\/vc_column_inner][\/vc_row_inner][vc_row_inner row_inner_height_percent=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; css=&#8221;.vc_custom_1651239577016{margin-bottom: 50px !important;}&#8221; limit_content=&#8221;&#8221;][vc_column_inner column_width_percent=&#8221;100&#8243; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/3&#8243; css=&#8221;.vc_custom_1746449305285{padding-top: 30px !important;}&#8221;][vc_single_image media=&#8221;1689&#8243; media_width_percent=&#8221;100&#8243;][\/vc_column_inner][vc_column_inner column_width_percent=&#8221;100&#8243; position_horizontal=&#8221;left&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;2\/3&#8243;][vc_column_text]<\/p>\n<h4 style=\"color: #d2214a; text-align: left;\">ANALYSE DES GREFFES DE CELLULES SOUCHES DANS LA LUTTE CONTRE LA DR\u00c9PANOCYTOSE.<\/h4>\n<p>[\/vc_column_text][vc_column_text]Cette analyse va permettre d\u2019\u00e9valuer l\u2019efficacit\u00e9 de ce type de greffe dans le traitement de la dr\u00e9panocytose.[\/vc_column_text][vc_column_text]<strong><em>Docteur Maria CAVAZZANNA<\/em> \u2013\u00a0<\/strong>Institut Imagine \u2013 H\u00f4pital Necker Paris[\/vc_column_text][vc_message message_color=&#8221;accent&#8221;]Budget allou\u00e9 sur 2 ans: 15.000 euros[\/vc_message][\/vc_column_inner][\/vc_row_inner][vc_row_inner row_inner_height_percent=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; css=&#8221;.vc_custom_1651239577016{margin-bottom: 50px !important;}&#8221; limit_content=&#8221;&#8221;][vc_column_inner column_width_percent=&#8221;100&#8243; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/3&#8243; css=&#8221;.vc_custom_1746449363556{padding-top: 30px !important;}&#8221;][vc_single_image media=&#8221;1697&#8243; media_width_percent=&#8221;100&#8243;][\/vc_column_inner][vc_column_inner column_width_percent=&#8221;100&#8243; position_horizontal=&#8221;left&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;2\/3&#8243;][vc_column_text]<\/p>\n<h4 style=\"color: #d2214a; text-align: left;\">COMPARAISON DES CAPACIT\u00c9S DES CELLULES SOUCHES DE SANG DE CORDONS ET DES CELLULES SOUCHES DE MOELLE OSSEUSE.<\/h4>\n<p>[\/vc_column_text][vc_column_text]<strong>Professeur Timoty DEVOS \u2013<\/strong> H\u00f4pital de Leuven Belgique[\/vc_column_text][vc_message message_color=&#8221;accent&#8221;]Budget allou\u00e9 sur 2 ans: 15.000 euros[\/vc_message][\/vc_column_inner][\/vc_row_inner][vc_row_inner row_inner_height_percent=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; css=&#8221;.vc_custom_1651239577016{margin-bottom: 50px !important;}&#8221; limit_content=&#8221;&#8221;][vc_column_inner column_width_percent=&#8221;100&#8243; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/3&#8243; css=&#8221;.vc_custom_1746449351029{padding-top: 30px !important;}&#8221;][vc_single_image media=&#8221;1701&#8243; media_width_percent=&#8221;100&#8243;][\/vc_column_inner][vc_column_inner column_width_percent=&#8221;100&#8243; position_horizontal=&#8221;left&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;2\/3&#8243;][vc_column_text]<\/p>\n<h4 style=\"color: #d2214a; text-align: left;\">MALADIE PSYCHIATRIQUE ET TH\u00c9RAPIE CELLULAIRE<\/h4>\n<p>[\/vc_column_text][vc_column_text]Il s\u2019agit de la mise en place d\u2019un r\u00e9seau destin\u00e9 \u00e0 l\u2019\u00e9tude des patients atteints de maladies psychiatriques en vue de leur qualification \u00e0 des protocoles de th\u00e9rapie cellulaire.<\/p>\n<p>Cette \u00e9tude prospective ouvre un champ de recherche tout nouveau et tr\u00e8s prometteur. Le d\u00e9marrage de ce projet permettra de d\u00e9terminer le r\u00f4le que pourront jouer les cellules souches.[\/vc_column_text][vc_column_text]<strong><em>Tamouza Ryad\u00a0<\/em><\/strong><em>\u2013 <\/em><em>Saint louis INSERN Paris\u00a0<\/em>[\/vc_column_text][vc_message message_color=&#8221;accent&#8221;]Poursuite du projet initi\u00e9 en 2014, budget allou\u00e9 sur 2 ans: 15.000 euros[\/vc_message][\/vc_column_inner][\/vc_row_inner][vc_row_inner row_inner_height_percent=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; css=&#8221;.vc_custom_1651239577016{margin-bottom: 50px !important;}&#8221; limit_content=&#8221;&#8221;][vc_column_inner column_width_percent=&#8221;100&#8243; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/3&#8243; css=&#8221;.vc_custom_1746449337693{padding-top: 30px !important;}&#8221;][vc_single_image media=&#8221;1694&#8243; media_width_percent=&#8221;100&#8243;][\/vc_column_inner][vc_column_inner column_width_percent=&#8221;100&#8243; position_horizontal=&#8221;left&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;2\/3&#8243;][vc_column_text]<\/p>\n<h4 style=\"color: #d2214a; text-align: left;\">MALADIES DU GREFFON CONTRE L\u2019H\u00d4TE<\/h4>\n<p>[\/vc_column_text][vc_column_text]Ce projet de recherche clinique a pour objet d\u2019\u00e9tudier l\u2019incidence, les facteurs de risque et les organes atteints apr\u00e8s une double greffe de sang placentaire chez les patients adultes porteurs de maladies h\u00e9matologiques malignes.<\/p>\n<p>En d\u2019autres termes, cette \u00e9tude retrospective va permettre d\u2019\u00e9valuer concr\u00e8tement les cons\u00e9quences des greffes de cellules souches du cordon ombilical d\u00e9j\u00e0 effectu\u00e9es. Elle sera men\u00e9e par le Professeur Eliane Gluckman pionni\u00e8re en mati\u00e8re de greffe de sang de cordons en s\u2019appuyant sur un fichier de 1200 patients r\u00e9f\u00e9renc\u00e9s.[\/vc_column_text][vc_column_text]<strong><em>Professeur Eliane Gluckman<\/em><\/strong><em>\u00a0<\/em><em>\u2013 Saint-Louis Paris<\/em>[\/vc_column_text][vc_message message_color=&#8221;accent&#8221;]Poursuite du projet initi\u00e9 en 2014, budget allou\u00e9 sur 2 ans: 20.000 euros[\/vc_message][\/vc_column_inner][\/vc_row_inner][vc_row_inner row_inner_height_percent=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; css=&#8221;.vc_custom_1651239577016{margin-bottom: 50px !important;}&#8221; limit_content=&#8221;&#8221;][vc_column_inner column_width_percent=&#8221;100&#8243; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/3&#8243; css=&#8221;.vc_custom_1746449325156{padding-top: 30px !important;}&#8221;][vc_single_image media=&#8221;1431&#8243; media_width_percent=&#8221;100&#8243;][\/vc_column_inner][vc_column_inner column_width_percent=&#8221;100&#8243; position_horizontal=&#8221;left&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;2\/3&#8243;][vc_column_text]<\/p>\n<h4 style=\"color: #d2214a; text-align: left;\">PROJET DE RECHERCHE CLINIQUE CONCERNANT L\u2019OXYG\u00c9NATION DES FEMMES ENCEINTES DR\u00c9PANOCYTAIRES.<\/h4>\n<p>[\/vc_column_text][vc_column_text]Ce projet, r\u00e9alis\u00e9 \u00e0 l\u2019h\u00f4pital Necker \u00e0 Paris dans le service Bioth\u00e9rapie, en lien avec le service de Gyn\u00e9cologie obst\u00e9trique et l\u2019observatoire de la dr\u00e9panocytose, va permettre d\u2019analyser les r\u00e9sultats d\u2019une suppl\u00e9mentation en oxyg\u00e8ne des femmes enceintes dr\u00e9panocytaires ainsi que le recueil de donn\u00e9es cl\u00e9s m\u00e9dicales concernant la dr\u00e9panocytose sur la m\u00e8re, l\u2019enfant \u00e0 na\u00eetre et les \u00e9ventuelles fratries. En plus du fait de soulager les souffrances parfois tr\u00e8s fortes de la femme enceinte dr\u00e9panocytaire, cet essai clinique va compl\u00e9ter les connaissances des m\u00e9decins sur la maladie pour permettre de mieux la soigner.[\/vc_column_text][vc_column_text]<strong><em>Maria Cavazzanna<\/em><\/strong>[\/vc_column_text][vc_message message_color=&#8221;accent&#8221;]Poursuite du projet initi\u00e9 en 2014, budget allou\u00e9 sur 2 ans: 20.000 euros[\/vc_message][\/vc_column_inner][\/vc_row_inner][\/vc_tab][vc_tab title=&#8221;2014&#8243; tab_id=&#8221;1650886552-1-6&#8243;][vc_row_inner row_inner_height_percent=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; css=&#8221;.vc_custom_1651239577016{margin-bottom: 50px !important;}&#8221; limit_content=&#8221;&#8221;][vc_column_inner width=&#8221;1\/3&#8243;][vc_single_image media=&#8221;1180&#8243; media_width_percent=&#8221;85&#8243; alignment=&#8221;center&#8221;][\/vc_column_inner][vc_column_inner column_width_percent=&#8221;100&#8243; position_horizontal=&#8221;left&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;2\/3&#8243;][vc_column_text]<\/p>\n<h4 style=\"color: #d2214a; text-align: left;\">MALADIE PSYCHIATRIQUE ET TH\u00c9RAPIE CELLULAIRE<\/h4>\n<p>[\/vc_column_text][vc_column_text]Il s\u2019agit de la mise en place d\u2019un r\u00e9seau destin\u00e9 \u00e0 l\u2019\u00e9tude des patients atteints de maladies psychiatriques en vue de leur qualification \u00e0 des protocoles de th\u00e9rapie cellulaire.<\/p>\n<p>Cette \u00e9tude prospective ouvre un champ de recherche tout nouveau et tr\u00e8s prometteur. Le d\u00e9marrage de ce projet permettra de d\u00e9terminer le r\u00f4le que pourront jouer les cellules souches.[\/vc_column_text][vc_column_text]<em><strong>Docteur Ryad Tamouza <\/strong><\/em>\u2013 INSERN H\u00f4pital Henry Mondor[\/vc_column_text][vc_message message_color=&#8221;accent&#8221;]Budget allou\u00e9 sur 2 ans : 15\u00a0000 euros[\/vc_message][\/vc_column_inner][\/vc_row_inner][vc_row_inner row_inner_height_percent=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; css=&#8221;.vc_custom_1651239577016{margin-bottom: 50px !important;}&#8221; limit_content=&#8221;&#8221;][vc_column_inner column_width_percent=&#8221;100&#8243; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/3&#8243; css=&#8221;.vc_custom_1746449570468{padding-top: 30px !important;}&#8221;][vc_single_image media=&#8221;1185&#8243; media_width_percent=&#8221;85&#8243; alignment=&#8221;center&#8221;][\/vc_column_inner][vc_column_inner column_width_percent=&#8221;100&#8243; position_horizontal=&#8221;left&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;2\/3&#8243;][vc_column_text]<\/p>\n<h4 style=\"color: #d2214a; text-align: left;\"><strong>MALADIES DU GREFFON CONTRE L\u2019H\u00d4TE<\/strong><\/h4>\n<p>[\/vc_column_text][vc_column_text]Ce projet de recherche clinique a pour objet d\u2019\u00e9tudier l\u2019incidence, les facteurs de risque et les organes atteints apr\u00e8s une double greffe de sang placentaire chez les patients adultes porteurs de maladies h\u00e9matologiques malignes.<\/p>\n<p>En d\u2019autres termes, cette \u00e9tude retrospective va permettre d\u2019\u00e9valuer concr\u00e8tement les cons\u00e9quences des greffes de cellules souches du cordon ombilical d\u00e9j\u00e0 effectu\u00e9es. Elle sera men\u00e9e par le Professeur Eliane Gluckman pionni\u00e8re en mati\u00e8re de greffe de sang de cordons en s\u2019appuyant sur un fichier de 1200 patients r\u00e9f\u00e9renc\u00e9s.[\/vc_column_text][vc_column_text]<em><strong>Professeur Eliane Gluckman <\/strong><\/em>\u2013 Saint-Louis Paris[\/vc_column_text][vc_message message_color=&#8221;accent&#8221;]Budget allou\u00e9 sur 2 ans : 20\u00a0000 euros[\/vc_message][\/vc_column_inner][\/vc_row_inner][vc_row_inner row_inner_height_percent=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; css=&#8221;.vc_custom_1651239577016{margin-bottom: 50px !important;}&#8221; limit_content=&#8221;&#8221;][vc_column_inner column_width_percent=&#8221;100&#8243; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/3&#8243; css=&#8221;.vc_custom_1746449556625{padding-top: 30px !important;}&#8221;][vc_single_image media=&#8221;1431&#8243; media_width_percent=&#8221;100&#8243;][\/vc_column_inner][vc_column_inner column_width_percent=&#8221;100&#8243; position_horizontal=&#8221;left&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;2\/3&#8243;][vc_column_text]<\/p>\n<h4 style=\"color: #d2214a; text-align: left;\">PROJET DE RECHERCHE CLINIQUE CONCERNANT L\u2019OXYG\u00c9NATION DES FEMMES ENCEINTES DR\u00c9PANOCYTAIRES.<\/h4>\n<p>[\/vc_column_text][vc_column_text]Ce projet, r\u00e9alis\u00e9 \u00e0 l\u2019h\u00f4pital Necker \u00e0 Paris dans le service Bioth\u00e9rapie, en lien avec le service de Gyn\u00e9cologie obst\u00e9trique et l\u2019observatoire de la dr\u00e9panocytose, va permettre d\u2019analyser les r\u00e9sultats d\u2019une suppl\u00e9mentation en oxyg\u00e8ne des femmes enceintes dr\u00e9panocytaires ainsi que le recueil de donn\u00e9es cl\u00e9s m\u00e9dicales concernant la dr\u00e9panocytose sur la m\u00e8re, l\u2019enfant \u00e0 na\u00eetre et les \u00e9ventuelles fratries. En plus du fait de soulager les souffrances parfois tr\u00e8s fortes de la femme enceinte dr\u00e9panocytaire, cet essai clinique va compl\u00e9ter les connaissances des m\u00e9decins sur la maladie pour permettre de mieux la soigner.[\/vc_column_text][vc_column_text]<em><strong>Maria Cavazzanna <\/strong>&#8211; H\u00f4pital Necker Paris<\/em>[\/vc_column_text][vc_message message_color=&#8221;accent&#8221;]Budget allou\u00e9 sur 2 ans : 20 000 euros[\/vc_message][\/vc_column_inner][\/vc_row_inner][\/vc_tab][vc_tab title=&#8221;2013&#8243; tab_id=&#8221;1650886552-2-76&#8243;][vc_row_inner row_inner_height_percent=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; css=&#8221;.vc_custom_1651239577016{margin-bottom: 50px !important;}&#8221; limit_content=&#8221;&#8221;][vc_column_inner column_width_percent=&#8221;100&#8243; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/3&#8243; css=&#8221;.vc_custom_1746449623754{padding-top: 30px !important;}&#8221;][vc_single_image media=&#8221;1703&#8243; media_width_percent=&#8221;100&#8243;][\/vc_column_inner][vc_column_inner column_width_percent=&#8221;100&#8243; position_horizontal=&#8221;left&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;2\/3&#8243;][vc_column_text]<\/p>\n<h4 style=\"color: #d2214a; text-align: left;\">SUIVI D\u2019UN REGISTRE INTERNATIONAL DE 1200 GREFF\u00c9S DR\u00c9PANOCYTAIRES.<\/h4>\n<p>[\/vc_column_text][vc_column_text]Cordons de vie a apport\u00e9 son soutien financier \u00e0 cette op\u00e9ration qui va permettre de suivre les patients dr\u00e9panocytaires greff\u00e9s par transfusion de cellules souches et ainsi de mieux analyser le devenir de ces patients. Les r\u00e9sultats devraient \u00eatre connus en d\u00e9cembre 2013 et la pr\u00e9sentation des r\u00e9sultats officiels faite aux Etats Unis lors d\u2019un grand congr\u00e8s.<\/p>\n<p>Ce soutien s\u2019inscrit dans un des objectifs de l\u2019Association : le soutien de la recherche et son application aupr\u00e8s des malades.[\/vc_column_text][vc_column_text]<strong><em>Eliane Gluckman <\/em><\/strong><em>\u2013 <\/em><em>Saint-Louis Paris <\/em>[\/vc_column_text][vc_message message_color=&#8221;accent&#8221;]Budget allou\u00e9 : 10.000 euros[\/vc_message][\/vc_column_inner][\/vc_row_inner][\/vc_tab][\/vc_tabs][\/vc_column][\/vc_row]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>[vc_row unlock_row=&#8221;&#8221; row_height_percent=&#8221;0&#8243; back_color=&#8221;color-xsdn&#8221; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; css=&#8221;.vc_custom_1654177569924{margin-top: 30px !important;}&#8221;][vc_column width=&#8221;1\/1&#8243;][vc_button button_color=&#8221;color-126273&#8243; size=&#8221;btn-xl&#8221; wide=&#8221;yes&#8221; outline=&#8221;yes&#8221; border_width=&#8221;0&#8243; icon_position=&#8221;right&#8221; link=&#8221;url:http%3A%2F%2Fcordonsdevie.org%2F%3Fpage_id%3D181%26lang%3Dfr|||&#8221; [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-1135","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/cordonsdevie.org\/index.php?rest_route=\/wp\/v2\/pages\/1135","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cordonsdevie.org\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/cordonsdevie.org\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/cordonsdevie.org\/index.php?rest_route=\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/cordonsdevie.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=1135"}],"version-history":[{"count":82,"href":"https:\/\/cordonsdevie.org\/index.php?rest_route=\/wp\/v2\/pages\/1135\/revisions"}],"predecessor-version":[{"id":1707,"href":"https:\/\/cordonsdevie.org\/index.php?rest_route=\/wp\/v2\/pages\/1135\/revisions\/1707"}],"wp:attachment":[{"href":"https:\/\/cordonsdevie.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=1135"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}